<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: QLTI News</title><copyright>Copyright (c) 2010 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=qlti</link><description>Latest Financial News for QLT Inc.</description><language>en-us</language><lastBuildDate>Wed, 30 Dec 2009 21:43:04 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>QLT INC/BC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091230/qlti8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/4160631057</guid><pubDate>Wed, 30 Dec 2009 21:43:04 Etc/GMT</pubDate></item><item><title>QLT Acquires Early-Stage Ophthalmic Asset for US$7.5 Million (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091230/180962.html?.v=1</link><description>VANCOUVER, British Columbia -- QLT Inc. today announced that the Company has acquired OT-730, a prodrug of a beta adrenergic antagonist under investigation for the treatment of glaucoma, from privately-held Othera Pharmaceuticals, Inc. and its wholly-owned subsidiary, Othera Holding, Inc. for a one-time payment of US$7.5 million in cash.</description><guid isPermaLink="false">yahoo_finance/571335853</guid><pubDate>Wed, 30 Dec 2009 21:30:00 Etc/GMT</pubDate></item><item><title>5 Value Stocks Worth Considering (at Seeking Alpha)</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12b6a6jca/*http%3A//seekingalpha.com/article/179686-5-value-stocks-worth-considering?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/25560578</guid><pubDate>Thu, 24 Dec 2009 08:06:27 Etc/GMT</pubDate></item><item><title>QLT Inc. establishes sales force in the United States (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091222/to787.html?.v=4</link><description>QLT Ophthalmics, Inc. will market Visudyne to retinal specialists across the U.S.-</description><guid isPermaLink="false">yahoo_finance/3173996515</guid><pubDate>Tue, 22 Dec 2009 12:00:00 Etc/GMT</pubDate></item><item><title>Prospecting for Stocks: QLT (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12lb8cb8r/*http%3A//www.fool.com/investing/general/2009/12/16/prospecting-for-stocks-qlti.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/1438956523</guid><pubDate>Wed, 16 Dec 2009 20:45:06 Etc/GMT</pubDate></item><item><title>QLT INC/BC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091215/qlti8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/1116217324</guid><pubDate>Tue, 15 Dec 2009 12:15:48 Etc/GMT</pubDate></item><item><title>QLT initiates Phase Ib study of QLT091001 in Leber Congenital Amaurosis (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091215/to637.html?.v=16</link><description></description><guid isPermaLink="false">yahoo_finance/1782401606</guid><pubDate>Tue, 15 Dec 2009 12:00:00 Etc/GMT</pubDate></item><item><title>QLT INC/BC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091209/qlti8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/2711562357</guid><pubDate>Wed, 9 Dec 2009 12:16:08 Etc/GMT</pubDate></item><item><title>6-month results from EVEREST study evaluating Visudyne(R) therapy in patients with polypoidal choroidal vasculopathy (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091209/to496.html?.v=10</link><description></description><guid isPermaLink="false">yahoo_finance/3283940786</guid><pubDate>Wed, 9 Dec 2009 12:00:00 Etc/GMT</pubDate></item><item><title>6-month results from EVEREST study evaluating Visudyne(R) therapy in patients with polypoidal choroidal vasculopathy (CNW Group)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/cnw/091209/qlt_visudyne_study.html?.v=2</link><description></description><guid isPermaLink="false">yahoo_finance/981683899</guid><pubDate>Wed, 9 Dec 2009 12:00:00 Etc/GMT</pubDate></item><item><title>QLT INC/BC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091201/qlti8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/1569161373</guid><pubDate>Tue, 1 Dec 2009 18:07:57 Etc/GMT</pubDate></item><item><title>Picks of the Week: Microsoft, H-P, Goldman, TiVo (at BusinessWeek)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://us.rd.yahoo.com/finance/editorial/xbizwk/SIG=12e7ti2vq/*http%3A//www.businessweek.com/investor/content/nov2009/pi20091127_523028.htm?campaign_id=yhoo</link><description></description><guid isPermaLink="false">yahoo_finance/2908574624</guid><pubDate>Mon, 30 Nov 2009 13:08:48 Etc/GMT</pubDate></item><item><title>Before the Bell: Renault, Dubai, QLT in focus (at MarketWatch)</title><link>http://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12c3984gt/*http%3A//www.marketwatch.com/news/story/renault-dubai-qlt-focus/story.aspx?guid=%7B20AB6614%2D9C0D%2D47F4%2D8368%2DA948A44A6498%7D&amp;siteid=yhoof</link><description>A roundup of financial and business news breaking before the opening bell on Wall Street.</description><guid isPermaLink="false">yahoo_finance/892501805</guid><pubDate>Fri, 27 Nov 2009 13:38:00 Etc/GMT</pubDate></item><item><title>QLT Inc upgraded by RBC Capital Mkts (Briefing.com)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/ud?s=QLTI</link><description></description><guid isPermaLink="false">yahoo_finance/569071431</guid><pubDate>Fri, 27 Nov 2009 12:40:12 Etc/GMT</pubDate></item><item><title>QLT INC/BC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091125/qlti8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/196516498</guid><pubDate>Wed, 25 Nov 2009 12:05:45 Etc/GMT</pubDate></item><item><title>QLT announces MGH litigation settlement (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091125/to924.html?.v=16</link><description>QLT Inc. today announced the settlement of its litigation with the General Hospital Corporation, doing business as Massachusetts General Hospital . Under the terms of the settlement agreement, QLT will pay US$20.0 million to MGH as payment in full for all past and future royalty obligations under the License Agreement between QLT and MGH, in exchange for the dismissal with prejudice of MGH&apos;s lawsuit against QLT pending in the Massachusetts District Court for violation of Massachusetts General Law Chapter 93A, sections 2 and 11.</description><guid isPermaLink="false">yahoo_finance/4126830885</guid><pubDate>Wed, 25 Nov 2009 12:00:00 Etc/GMT</pubDate></item><item><title>3 Stocks Hitting High Notes (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12li4sppe/*http%3A//www.fool.com/investing/general/2009/11/06/3-stocks-hitting-high-notes.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/178959376</guid><pubDate>Fri, 6 Nov 2009 18:52:38 Etc/GMT</pubDate></item><item><title>QLT INC/BC Files SEC form 10-Q, Quarterly Report (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091106/qlti10-q.html</link><description></description><guid isPermaLink="false">yahoo_finance/3666744706</guid><pubDate>Fri, 6 Nov 2009 11:02:48 Etc/GMT</pubDate></item><item><title>CEO Interview: Provectus Pharmaceuticals, Inc. - Peter R. Culpepper (Wall Street Transcript)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/twst/091102/ang611.html?.v=2</link><description></description><guid isPermaLink="false">yahoo_finance/1658094216</guid><pubDate>Mon, 2 Nov 2009 20:09:00 Etc/GMT</pubDate></item><item><title>Pay Attention To QLT (at Investopedia)</title><link>http://us.rd.yahoo.com/finance/external/investopedia/rss/SIG=135ajlnjc/*http%3A//stocks.investopedia.com/stock-analysis/2009/Pay-Attention-To-QLT-QLTI-SNY-NVS-JNJ1029.aspx?partner=YahooSA</link><description></description><guid isPermaLink="false">yahoo_finance/2477084859</guid><pubDate>Thu, 29 Oct 2009 22:17:19 Etc/GMT</pubDate></item></channel></rss><!-- c21.finance.sp2.yahoo.com compressed/chunked Wed Jan  6 09:52:17 PST 2010 -->
